New Vaccine With 100 Percent Efficacy Against Severe COVID-19 Seeks Approval
A new COVID-19 vaccine has achieved 100 percent efficacy against severe disease and hospitalizations, announced manufacturers Sanofi and GSK on Wednesday.
Stay updated with breaking news from Thomas Triomphe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new COVID-19 vaccine has achieved 100 percent efficacy against severe disease and hospitalizations, announced manufacturers Sanofi and GSK on Wednesday.
Investegate announcements from Sanofi - Aventis Groupe, Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine
French pharmaceuticals giant Sanofi said Wednesday that its Covid-19 vaccine, developed with Britain's GSK, had delivered positive results after nearly a year of delays left it lagging far behind its…
WEDNESDAY, Feb. 23, 2022 (HealthDay News) -- Two doses of a new COVID-19 vaccine from Sanofi and GSK were 100% effective against severe disease and hospitalizations, the companies announced Wednesday.
It was also more than 50% sufficient against all symptomatic Covid